Bifidobacterium and Escherichia guilds reshape gut metabolism in tuberculosis

Researchers are increasingly interested in the trillions of microbes that live in the human gut and how they help keep our immune system in balance. But many studies look only at individual species, missing how groups of microbes that live together—so-called ecological guilds—work as a team. In new work led by Milyausha M. Yunusbaeva, scientists tackled that gap by analyzing fecal microbiota from people with tuberculosis and from healthy controls to find community-level patterns. Rather than reporting lists of individual bacteria, the team reconstructed co-occurring ecological partners to understand their joint metabolic functions. By grouping microbes into meaningful community units, the study aimed to connect those community patterns to host biomarkers and disease, and to reveal how altered gut communities might change the biochemical environment inside the gut. This community-focused approach sets out to capture functions that single-species analyses can miss and to give a clearer picture of how the microbiome as a whole may be altered in tuberculosis.

To uncover community-level structure, the researchers decomposed fecal microbiota into five key bacterial enterosignatures (ESs) using non-negative matrix factorization (NMF). This mathematical tool let them group individual microbes into ecological units that better reflect shared behavior and function. Comparing tuberculosis patients to healthy controls, they found that healthy participants carried the same mixture of ecological guilds seen in worldwide donor collections, while tuberculosis patients showed unusual enrichment of two enterosignatures, named ES-Bifi and ES-Esch. The team inferred which metabolic pathways were enriched in those two ESs and found a clear pattern: members of ES-Bifi and ES-Esch rely on rapid growth strategies driven by anaerobic glycolysis, which in turn produces abundant fermentation products such as acetate and lactate. A higher number of bacteria using anaerobic glycolysis suggested greater glucose availability in the gut communities of patients. The authors hypothesize that this excess fermentation into lactate could acidify the gut environment and suppress normal flora, patterns that were evident in the patient samples.

The findings highlight why it matters to study microbiomes as living communities rather than just lists of species. By defining reproducible ecological guilds called enterosignatures, the work provides a consistent framework for comparing gut communities across studies and populations. For tuberculosis patients, the dominance of ES-Bifi and ES-Esch points to a shift toward fast-growing, fermenting bacteria that change chemical conditions in the gut—more acetate and lactate, and possibly a lower pH—that could interfere with the usual beneficial microbes. Understanding these community-level metabolic changes can help researchers link gut ecology to host immune homeostasis and disease processes. The study also suggests new angles for monitoring or modifying the gut environment in patients: instead of targeting single microbes, interventions might aim to restore balanced guilds or to counteract metabolic consequences such as excess lactate production and acidification.